CommentPoint-of-care tuberculosis diagnosis: are we there yet?
References (13)
- et al.
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
Lancet
(2010) - et al.
Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis
Trans R Soc Trop Med Hyg
(2005) - et al.
Towards lab-free tuberculosis diagnosis
Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system
(2011)- Grenier J, Pinto LM, Nair D, et al. Widespread use of serological tests for tuberculosis: data from 22 high-burden...
- et al.
Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis
PLoS Med
(2011)
Cited by (23)
Diagnosis of pulmonary tuberculosis and assessment of treatment response through analyses of volatile compound patterns in exhaled breath samples
2017, Journal of InfectionCitation Excerpt :Breath samples are simple to collect and analyze, allowing for frequent measurements over time aimed at determining clinical progression or treatment response. Further, available sensor technology also allows exhaled-breath analysis at the point-of-care circumventing the need for high-infrastructure and expensive programs in low-income countries.3 Broadly speaking, the analyses of VOCs for diagnostic or prognostic purposes could use two complementary, not mutually exclusive approaches.
ABCs of DNA aptamer and related assay development
2017, Biotechnology AdvancesCitation Excerpt :This will certainly minimize labor, cost and post-development modifications and alterations. There are five TPPs that are helpful at various levels like TPP1 (home/industry), TPP2 (communities), TPP3 (clinics), TPP4 (diagnostics labs or labs present in industry settings) and TPP5 (hospitals) (Denkinger and Pai, 2012; Pai et al., 2012). Defining the TPP at the outset may hasten the process of designing a prototype as per the end user needs.
Point-of-care assays for tuberculosis: Role of nanotechnology/microfluidics
2013, Biotechnology AdvancesCitation Excerpt :Thus, the LAM lateral flow test may aid management of AIDS patients in Sub-Saharan countries where TB is the leading cause of death. Nevertheless, rigorous field evaluation is needed to assess the diagnostic utility of this test as a rule-in assay for detection of active TB cases in various AIDS populations (e.g., women and children) in resource-constrained settings (Denkinger and Pai, 2012; Lawn et al., 2012; Peter et al., 2012). Owing to low-cost, simplicity and rapidity, lateral-flow immunochromatographic commercial tests for detection of antibodies in blood specific for mycobacterial antigens have been widely used in the developing world having high burden of TB.
The global HIV response at 40
2022, African Journal of AIDS Research